Healthy Volunteer Study

InventisBio

Status and phase: Enrolling; Phase 1

Conditions: Healthy Volunteer

Treatments: Drug: Placebo; Drug: D-2570

Study type: Interventional

Funder types: Industry

Identifiers

NCT07270783

D2570-103

Details and patient eligibility

About

Double Blinded Healthy Volunteer study evaluating D-2570 against placebo in various doses.

Full description

Double blind study evaluating the safety, tolerability and PK data of D-2570/placebo in healthy volunteers.

Enrollment: 36 estimated patients

Sex: All

Ages: 18 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy volunteer subjects meeting eligibility criteria

Exclusion criteria

• Subjects with ongoing or history of disease or co-morbidities as assessed by Principal Investigator which would make them ineligible for the study
• Subjects with a history of drug and alcohol abuse
• Subjects taking medications, over the counter or herbal remedies

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

36 participants in 3 patient groups

Cohort 1 D-2570/Placebo

Experimental group

Treatment:

Drug: Placebo

Drug: D-2570

Cohort 2 D-2570/Placebo

Experimental group

Treatment:

Drug: Placebo

Drug: D-2570

Cohort 3 D-2570/Placebo

Experimental group

Treatment:

Drug: Placebo

Drug: D-2570